Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.
Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coudé M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourlière M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, Thiefin G, Buffet-Janvresse C, Riachi G, Grattard F, Bourlet T, Stoll-Keller F, Doffoel M, Izopet J, Barange K, Martinot-Peignoux M, Branger M, Rosenberg A, Sogni P, Chaix ML, Pol S, Thibault V, Opolon P, Charrois A, Serfaty L, Fouqueray B, Grange JD, Lefrère JJ, Lunel-Fabiani F. Payan C, et al. Among authors: marcellin p. J Viral Hepat. 2005 Jul;12(4):405-13. doi: 10.1111/j.1365-2893.2005.00605.x. J Viral Hepat. 2005. PMID: 15985012
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.
Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, Coste J, Izopet J, Duverlie G, Payan C, Pawlotsky JM, Defer C, Bogard M, Gerolami V, Halfon P, Buisson Y, Fouqueray B, Loiseau P, Lamoril J, Lefrere JJ, Marcellin P. Martinot-Peignoux M, et al. Among authors: marcellin p. J Viral Hepat. 1999 Nov;6(6):435-43. doi: 10.1046/j.1365-2893.1999.00187.x. J Viral Hepat. 1999. PMID: 10607261
Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study.
Semenova T, Nemoz B, Thibault V, Lagathu G, Duverlie G, Brochot E, Trimoulet P, Payan C, Vallet S, Henquell C, Chevaliez S, Bouvier-Alias M, Maylin S, Roque-Afonso AM, Izquierdo L, Lunel-Fabiani F, Marcellin P, Morand P, Leroy V, Larrat S. Semenova T, et al. Among authors: marcellin p. Epidemiol Infect. 2019 Jan;147:e234. doi: 10.1017/S0950268819001225. Epidemiol Infect. 2019. PMID: 31364570 Free PMC article.
GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum.
Bogard M, Buffet-Janvresse C, Cantaloube JF, Biagini P, Duverlie G, Castelain S, Izopet J, Dubois M, Defer C, Lepot I, Coste J, Marcellin P, Martinot-Peignoux M, Halfon P, Gerolami V, Frangeul L, Pawlotsky JM, Roudot-Thoraval F, Dussaix E, Loiseau P, Ravera N, Lewin P, Lamoril J, Lerable J, Lebon P, et al. Bogard M, et al. Among authors: marcellin p. J Clin Microbiol. 1997 Dec;35(12):3298-300. doi: 10.1128/jcm.35.12.3298-3300.1997. J Clin Microbiol. 1997. PMID: 9399538 Free PMC article. Clinical Trial.
Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay.
Lefrère JJ, Lerable J, Mariotti M, Bogard M, Thibault V, Frangeul L, Loiseau P, Bouchardeau F, Laperche S, Pawlotsky JM, Cantaloube JF, Biagini P, de Lamballerie X, Izopet J, Defer C, Lepot I, Poveda JD, Dussaix E, Gerolami V, Halfon P, Buffet-Janvresse C, Férec C, Mercier B, Marcellin P, Martinot-Peignoux M, Gassain M. Lefrère JJ, et al. Among authors: marcellin p. J Virol Methods. 2000 Mar;85(1-2):117-24. doi: 10.1016/s0166-0934(99)00160-3. J Virol Methods. 2000. PMID: 10716345
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial.
Poynard T, Marcellin P, Bissery A, Myers RP, Moussalli J, Degos F, Dhumeaux D, Riachi G, Bronowicki JP, Brissot P, Buffet C, Serfaty L, Naveau S, Sogni P, Beaugrand M, Gayno S, Larrey D, Samuel D, Eugene C, Pol S, Bedossa P, Daurat V, Chaumet-Riffaud P; GER-CYT-RIBANON group. Poynard T, et al. Among authors: marcellin p. J Viral Hepat. 2003 May;10(3):197-204. doi: 10.1046/j.1365-2893.2003.00427.x. J Viral Hepat. 2003. PMID: 12753338 Clinical Trial.
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.
Roulot D, Bourcier V, Grando V, Deny P, Baazia Y, Fontaine H, Bailly F, Castera L, De Ledinghen V, Marcellin P, Poupon R, Bourlière M, Zarski JP, Roudot-Thoraval F; Observational VHC4 Study Group. Roulot D, et al. Among authors: marcellin p. J Viral Hepat. 2007 Jul;14(7):460-7. doi: 10.1111/j.1365-2893.2006.00823.x. J Viral Hepat. 2007. PMID: 17576387
558 results